RecruitingNCT07163689

TIPS for Complicated Portal Hypertension Related to Porto-Sinusoidal Vascular Disease

TIPS for the Management of Complicated Portal Hypertension Related to Porto-Sinusoidal Vascular Disease


Sponsor

Centre Hospitalier Universitaire, Amiens

Enrollment

360 participants

Start Date

May 16, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Porto-sinusoidal Vascular Disease (PSVD) is characterized by a portal hypertension (PH) without cirrhosis. This can induce PH complications, like digestive hemorrhage from esophageal or gastric varices, ascites, or even portal thrombosis. Due to the rarity of MVPS, the treatment of complications of portal hypertension is modeled on the methods used in cirrhotic portal hypertension with non-cardio-selective beta blockers, endoscopic ligations or diuretics in first line therapy, as proposed by the Baveno VII recommendations. In complicated or refractory forms of PH in PSVD, the place of TIPS is also discussed, as in the field of cirrhosis. However, the experience of TIPS in PSVD is limited, reported in case reports and small specifically dedicated series. No predictive factors for survival or recurrence and tolerance were well known. A larger study with control group is needed in order to better know the right time and the right indication for the use of TIPS in complicated PH PSVD-related. The study will be retrospective, multicentric involving tertiary university French centers, expert in the management of TIPS. Patients white TIPS-PSVD will be compared with historical patients with TIPS-cirrhose, matched on age, sexe, indication of TIPS. The study will not comprise new intervention, only observational in a real life condition


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study examines how well a procedure called TIPS (transjugular intrahepatic portosystemic shunt — a small tube placed inside the liver to redirect blood flow) works in people with a rare liver condition called porto-sinusoidal vascular disease (PSVD), compared to people with more common liver cirrhosis. Both groups have high blood pressure in the portal vein (the main vein feeding the liver). **You may be eligible if...** - You have been diagnosed with PSVD (a specific type of non-cirrhotic liver disease) or confirmed cirrhosis - You are receiving a TIPS procedure for bleeding from varices, severe fluid buildup (refractory ascites), or a blood clot in the portal vein **You may NOT be eligible if...** - Your diagnosis of PSVD has not been formally confirmed - You have Budd-Chiari syndrome, heart failure, sarcoidosis, blood vessel tumors, or certain other liver conditions Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

CHU Amiens Picardie

Amiens, Picardie, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07163689


Related Trials